Evidence map›Paper›PMID 38999106›Full record

ArticleMolecules (Basel, Switzerland)2024

Synthesis and Investigation of Biological Activity of New Betulonic Acid Derivatives Containing 1,2,3-Triazole Fragments.

Roza I Jalmakhanbetova, Gulim K Mukusheva, Alisher Sh Abdugalimov, Zharkyn Zh Zhumagalieva, Wim Dehaen, Stijn Anthonissen, Yerlan M Suleimen, Roza B Seidakhmetova

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Roza I JalmakhanbetovaDepartment of Chemistry, Faculty of Natural Sciences, L.N. Gumilyov Eurasian National University, Astana 010000, Kazakhstan.ORCID 0000-0001-9937-275X
Gulim K MukushevaFaculty of Chemistry, Karaganda Buketov University, Karaganda 100024, Kazakhstan.
Alisher Sh AbdugalimovDepartment of Chemistry, Faculty of Natural Sciences, L.N. Gumilyov Eurasian National University, Astana 010000, Kazakhstan.ORCID 0009-0004-8864-9230
Zharkyn Zh ZhumagalievaPedagogical Institute, Astana International University, Astana 010000, Kazakhstan.
Wim DehaenDepartment of Chemistry, KU Leuven, Celestijnenlaan 200F, B-3001 Leuven, Belgium.ORCID 0000-0002-9597-0629
Stijn AnthonissenDepartment of Chemistry, KU Leuven, Celestijnenlaan 200F, B-3001 Leuven, Belgium.ORCID 0000-0002-2627-067X
Yerlan M SuleimenDepartment of Chemistry, Chemical Technology and Ecology, Faculty of Technology, K. Kulazhanov Kazakh University of Technology and Business, Astana 010000, Kazakhstan.ORCID 0000-0002-5959-4013
Roza B SeidakhmetovaDepartment of Clinical Pharmacology and Evidence-Based Medicine, Karaganda Medical University, Karaganda 100024, Kazakhstan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The results of this study showed that the compounds synthesized by the authors have significant potential due to their antibacterial and cytotoxic properties. The apparent antibacterial activity demonstrated by the compounds suggests that they are active antimicrobial agents against common microbial pathogens that cause various socially significant infectious diseases. Compound

Indexed as

Anti-Bacterial AgentsEscherichia coliMicrobial Sensitivity TestsStaphylococcus aureusTriazolesHumansMolecular StructureStructure-Activity RelationshipAnti-Bacterial AgentsTriazolesantimicrobial activitybetulonic acidchemical transformationcytotoxicitylupanenatural productspectroscopic methodsynthesistriterpenoid

Identifiers

PMID38999106
PMCPMC11243376

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.